[HTML][HTML] Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis

J Mao, Q Zhang, H Zhang, K Zheng, R Wang… - Frontiers in …, 2020 - frontiersin.org
Purpose: To explore the risk factors that may predict the lymph node metastasis potential of
these lesions and new prevention strategies in papillary thyroid carcinoma patients …

Improving the measurement of serum thyroglobulin with mass spectrometry

AN Hoofnagle, MY Roth - The Journal of Clinical Endocrinology …, 2013 - academic.oup.com
Context: Serum thyroglobulin (Tg) measurements are central to the management of patients
treated for differentiated thyroid carcinoma. For decades, Tg measurements have relied on …

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and …

Y Ito, N Onoda, T Okamoto - Endocrine journal, 2020 - jstage.jst.go.jp
Abstract The Japan Associations of Endocrine Surgeons has developed the revised version
of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines …

[HTML][HTML] Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus

PW Rosário, LS Ward, GA Carvalho, H Graf… - … de Endocrinologia & …, 2013 - SciELO Brasil
Thyroid nodules are frequent findings, especially when sensitive imaging methods are used.
Although thyroid cancer is relatively rare, its incidence is increasing, particularly in terms of …

[HTML][HTML] Consenso intersocietario* sobre tratamiento y seguimiento de pacientes con cáncer diferenciado de tiroides

F Pitoia, I Califano, A Vázquez, E Faure… - Revista argentina de …, 2014 - SciELO Argentina
La incidencia del cáncer diferenciado de tiroides se incrementó exponencialmente en todo
el mundo. Aunque estos tumores presentan un pronóstico excelente, se produjeron …

Endocrine tumours: imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach

L Lamartina, D Deandreis, C Durante… - European Journal of …, 2016 - academic.oup.com
The clinical and epidemiological profiles of differentiated thyroid cancers (DTCs) have
changed in the last three decades. Today's DTCs are more likely to be small, localized …

[HTML][HTML] Nódulo tireoidiano e câncer diferenciado de tireoide: atualização do consenso brasileiro

PW Rosário, LS Ward, GA Carvalho, H Graf… - Arquivos brasileiros de …, 2013 - SciELO Brasil
Thyroid nodules are frequent findings, especially when sensitive imaging methods are used.
Although thyroid cancer is relatively rare, its incidence is increasing, particularly in terms of …

Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?

PW Rosario, GF Mourao, JBN dos Santos… - Thyroid, 2014 - liebertpub.com
Background: At present, empirical radioactive iodine therapy is recommended for patients
with thyroid cancer and elevated thyroglobulin (Tg) after initial therapy when neck …

[PDF][PDF] Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer

X Zhang, X Zhang, Z Chang, C Wu, H Guo - J BUON, 2018 - jbuon.com
Purpose: To investigate the feasibilities and clinical values of thyroid-stimulating hormone
(TSH) and thyroid autoantibodies in predicting differentiated thyroid cancer (DTC). Methods …

A low postoperative nonstimulated serum thyroglobulin level excludes the presence of persistent disease in low‐risk papillary thyroid cancer patients: implication for …

PW Rosario, GF Mourão, TL Siman… - Clinical …, 2015 - Wiley Online Library
Objective To evaluate the presence of persistent disease, including on post‐therapy whole‐
body scan (Rx WBS), in low‐risk patients with papillary thyroid carcinoma (PTC)> 1 cm who …